TrialPanorama/TrialPanorama-database huggingface dataset:
Study: NCT06732167

Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: GBR Lyoplant
Description: GBR surgical procedure with simultaneous implant placement including membrane placement

Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: GBR Bio-Gide
Description: GBR surgical procedure with simultaneous implant placement including membrane placement
Study: NCT06423300

Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: LIFT Implant
Description: The LIFT implant provides a less invasive option for treatment of patellofemoral cartilage degeneration in the knee. the LIFT implant unloads the patellofemoral joint by elevating the patellar tendon to unload the joint compartment and realign the kneecap toward healthier cartilage

Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Tibial Tubercle Osteotomy
Description: Tibial Tubercle Osteotomy
Study: NCT06734858

Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: SAT014
Description: SAT-014 in Combination with Baseline Conventional Treatment Participants in this arm will use the SAT-014 application for 6 weeks in combination with their baseline conventional treatment, which may include pharmacological therapy or simple counseling (excluding cognitive behavioral therapy and psychoanalytic counseling therapy). The aim of this study is to assess the efficacy and safety of SAT-014 for alleviating symptoms of trauma and stressor-related disorders, such as PTSD and adjustment disorder.

Intervention type: OTHER
Group type: OTHER
Intervention: Control
Description: Baseline Conventional Treatment Participants in this arm will receive only conventional treatment, which includes the medication they were taking at baseline for the indication or the basic counseling therapy they were receiving at baseline.
Study: NCT06744764

Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: PEMF (1mT)
Description: 1mT of field strength will be given to patients/healthy volunteers for 10 minutes, twice per week for 4 consecutive weeks.

Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: PEMF (1mT)
Description: 1mT of field strength will be given to patients/healthy volunteers for 10 minutes, twice per week for 4 consecutive weeks.

Intervention type: DEVICE
Group type: SHAM_COMPARATOR
Intervention: PEMF (0mT)
Description: Healthy volunteers will place their legs in the PEMF device, twice per week for 4 consecutive weeks. However, no magnetic stimulation will be given.
Study: NCT06743750

Intervention type: DIAGNOSTIC_TEST
Intervention: RT-PCR in different respiratory tract samples
Description: RT-PCR on saliva, orrobuccal swab and nasal swab will be performed. Nasopharyngeal swab will be performed independently of the study as standard of care.
Study: NCT06750107

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Safe South Africa
Description: The Safe South Africa intervention is a gender- and developmentally-tailored, designed to reduce actual or intended HIV risk behaviors, actual or intended IPV perpetration frequency, and endorsement of IPV supportive attitudes. This intervention comprises 2-hour sessions, held once a week for a total of two weeks. The intervention also includes take-home activities to deepen behavioral engagement with received sessions and to prime the pump for up-coming sessions. Part 2 involves behavioral practice, including bystander intervention techniques.
Study: NCT06757452

Intervention type: DIETARY_SUPPLEMENT
Group type: EXPERIMENTAL
Intervention: Supplement with curcuminoids
Description: Cal LX is a food-grade dietary supplement based on turmeric, it has been designed to improve physical resistance during exercise, accelerate post-exercise recovery, and reduce the feeling of muscle soreness. Cal LX was determined as not cytotoxic or genotoxic. The supplement or placebo dosage was one (1) 250 mg capsule 45 minutes before exercising.

Intervention type: OTHER
Group type: PLACEBO_COMPARATOR
Intervention: Physical excercise
Description: Participants performed 45 minutes of physical activity twice a week. The intervention program included a five-minute warm-up, composed of two series of joint mobility and three series of eight seconds of lower limbs stretching. Then, a routine of intermittent training composed of four six-minute rounds was directed. Each routine included running for 10 seconds and a pause between them. The first round had a 20 s pause, the second round 15 s, and the third and fourth rounds 10 s. Between the rounds was a two-minute passive pause. Finally, three series of twenty seconds of elongation of the lower extremities were required as colling down.

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Physical excercise
Description: Participants performed 45 minutes of physical activity twice a week. The intervention program included a five-minute warm-up, composed of two series of joint mobility and three series of eight seconds of lower limbs stretching. Then, a routine of intermittent training composed of four six-minute rounds was directed. Each routine included running for 10 seconds and a pause between them. The first round had a 20 s pause, the second round 15 s, and the third and fourth rounds 10 s. Between the rounds was a two-minute passive pause. Finally, three series of twenty seconds of elongation of the lower extremities were required as colling down.
Study: NCT06748911

Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: NaviCam Detachable String Capsule
Description: Subjects will swallow the NaviCam capsule with 20 ml water while positioned in the upright position. Once the capsule reaches the gastric cardia, the string will slowly be pulled up to systematically inspect the Z-line and upper, middle, and lower thirds of the esophagus guided by real-time viewing and by moving the capsule solely with the tether. Images will be captured at a rate of 2 frames per second.

Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: NaviCam Detachable String Capsule
Description: Subjects will swallow the NaviCam capsule with 20 ml water while positioned in the upright position. Once the capsule reaches the gastric cardia, the string will slowly be pulled up to systematically inspect the Z-line and upper, middle, and lower thirds of the esophagus guided by real-time viewing and by moving the capsule solely with the tether. Images will be captured at a rate of 2 frames per second.

Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: NaviCam Detachable String Capsule
Description: Subjects will swallow the NaviCam capsule with 20 ml water while positioned in the upright position. Once the capsule reaches the gastric cardia, the string will slowly be pulled up to systematically inspect the Z-line and upper, middle, and lower thirds of the esophagus guided by real-time viewing and by moving the capsule solely with the tether. Images will be captured at a rate of 2 frames per second.
Study: NCT06761612

Intervention type: BIOLOGICAL
Intervention: FDA approved mRNA vaccines
Description: This study is non-interventional as participants will have received an FDA approved mRNA COVID-19 vaccine prior to entering the study. The study protocol does not determine or allocate receipt of vaccine

Intervention type: BIOLOGICAL
Intervention: FDA approved mRNA vaccines
Description: This study is non-interventional as participants will have received an FDA approved mRNA COVID-19 vaccine prior to entering the study. The study protocol does not determine or allocate receipt of vaccine
Study: NCT06762548

Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: DA-007
Description: Topical α1 agonist combination of Phenylephrine + Tyramine + Synephrine

Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Description: Topical placebo solution
Study: NCT06764017

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: CHiR-DEL
Description: Using the combined regimen of CHiR (chidamide, zanubrutinib, and lenalidomide) to treat newly diagnosed elderly patients with MYC- and BCL2-expressing positive diffuse large B-cell lymphoma (DLBCL) who are intolerant to chemotherapy.
Study: NCT06763042

Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Mindfulness-based Life Management Social Robots
Description: Mindfulness-based life management contents for pediatric patients operated by Social Robots
Study: NCT06763770

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Managing Your Health (MYH)
Description: The Managing Your Health intervention consists of six weekly videoconference calls with a peer mentor and five self-management educational modules within a mobile application. The first call is to get to know each other, share survivorship stories, identify self-management strengths and weaknesses, and select goals for participation in the intervention. The remaining five weekly calls cover a self-management topic each week, including understanding your survivorship care plan, navigating the healthcare system and insurance, managing the emotional aspects of survivorship, negotiating family and significant other involvement in care, and engaging in healthy lifestyle behaviors.

Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: The Usual Care + Educational Control
Description: The Usual Care + Educational Control group will receive weekly emails with links to the Health Links developed by the Children's Oncology Group for use in survivorship care. Access to these Health Links reflects the current state of clinical care available to survivors. These Health Links were developed as patient education materials to cover relevant self-management and survivorship care topics. The weekly messages will align with the content of the modules from Managing Your Health to provide similar information, including Introduction to Long-Term Follow-Up (Module 1), Finding and Paying for Healthcare (Module 2), Emotional Issues (Modules 3 and 4), Educational Issues, Diet and Physical Activity, Skin Health, Reducing the Risk of Second Cancers, and Male/Female Health Issues (Module 5).
Study: NCT06763900

Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Skeletal anchorage and intermaxillary elastic assisted maxillary protraction
Description: maxillary protraction with corticotomy-assisted different miniplate and intermaxillary elastic applications after growth spurt in patients with skeletal Class III malocclusion

Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Skeletal anchorage and intermaxillary elastic assisted maxillary protraction
Description: maxillary protraction with corticotomy-assisted different miniplate and intermaxillary elastic applications after growth spurt in patients with skeletal Class III malocclusion

Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Skeletal anchorage and intermaxillary elastic assisted maxillary protraction
Description: maxillary protraction with corticotomy-assisted different miniplate and intermaxillary elastic applications after growth spurt in patients with skeletal Class III malocclusion
Study: NCT06760767

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: sexual therapy
Description: In sexual therapy sessions, sexual education, cognitive restructuring, body awareness exercises, systematic desensitization, relaxation training, individual and partner home exercise training and dilator treatment were applied with the supervision of a physiotherapist. All techniques and stages were not applied in the same session and were used with a certain progression

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: sexual therapy
Description: In sexual therapy sessions, sexual education, cognitive restructuring, body awareness exercises, systematic desensitization, relaxation training, individual and partner home exercise training and dilator treatment were applied with the supervision of a physiotherapist. All techniques and stages were not applied in the same session and were used with a certain progression

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Pelvic floor physiotherapy combined with sexual therapy
Description: Pelvic floor physiotherapy combined with sexual therapy was applied in the experimental group. Sexual therapy techniques were added appropriately before, during and after the pelvic floor physiotherapy session. In the pelvic floor physiotherapy sessions, pelvic floor muscle training, biofeedback, electrotherapy, manual therapy applications, breathing exercises, stretching and relaxation exercises were applied with the physiotherapist. Pelvic floor physiotherapy techniques and stages were applied in the same session and followed a certain progression.
Study: NCT06763211

Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Chlorhexidine Hair Bath
Description: Intervention group 1 will have a hair bath with 5 ml of chlorhexidine gluconate solution 2 times consecutively. Intervention group 2 will first be given a hair bath using the patient's soap or shampoo. Afterwards, the hair will be bathed 2 times consecutively with 5 ml chlorhexidine gluconate solution. Hair bath will be given to the control group using the patient's own soap or shampoo. Surgical site infection follow-up form, laboratory findings form, vital signs form, culture follow-up form will be filled out before and after banyadon. Additionally, cultures will be taken from the surgical area with hair immediately after bathing, on the 2nd post-operative day, and on the day the stitches are removed.

Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Chlorhexidine Hair Bath
Description: Intervention group 1 will have a hair bath with 5 ml of chlorhexidine gluconate solution 2 times consecutively. Intervention group 2 will first be given a hair bath using the patient's soap or shampoo. Afterwards, the hair will be bathed 2 times consecutively with 5 ml chlorhexidine gluconate solution. Hair bath will be given to the control group using the patient's own soap or shampoo. Surgical site infection follow-up form, laboratory findings form, vital signs form, culture follow-up form will be filled out before and after banyadon. Additionally, cultures will be taken from the surgical area with hair immediately after bathing, on the 2nd post-operative day, and on the day the stitches are removed.
Study: NCT06763497

Intervention type: OTHER
Group type: OTHER
Intervention: Systematic Oral Feeding Education Program
Description: The experimental group will receive 11 intervention sessions during the study period. The first intervention will occur immediately after the pretest and will involve a systematic oral feeding education program, including guided feeding techniques and practical feeding demonstrations. During the feeding session, caregivers' practices will be recorded on video. These recordings will then be reviewed with the caregiver to identify areas for improvement.The remaining 10 intervention sessions will take place daily on days 2-4, 6-9, and 11-13, during which the researcher will observe the primary caregiver's feeding practices, provide assistance, and offer tailored suggestions. On the 14th day, the experimental group will complete the same posttest assessments as the control group.
Study: NCT06764797

Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: Transcranial Direct Current Stimulation
Description: tDCS will be used during the sessions. The anodal tDCS (2 mA) will be applied for 20 minutes. Continuous, direct currents. The anodal electrode will be positioned over the ipsilesional primary motor cortex (M1) (C3 or C4, international 10-20 system) of the affected hemisphere and the cathodal electrode over the contralateral orbit.

Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: Virtual reality
Description: The VRMT group will receive VRMT game-based training using their non-affected upper limb. using a semi-immersive motion-tracking device.

Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Transcranial Direct Current Stimulation compined with virtual reality based mirror therapy
Description: 20 minutes of tDCS during 45 minutes of VRMT games.

Intervention type: OTHER
Group type: SHAM_COMPARATOR
Intervention: Conventional physical therapy
Description: 45 minutes of conventional physical therapy with sham tDCS
Study: NCT06763705

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Midazolam
Description: It will not be used alone but in combination with Fentanyl in the Midazolam + Fentanyl group.

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Propofol
Description: It will used alone in Propofol group and in combination with Fentanyl in the Propofol + Fentanyl group.

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Propofol
Description: It will used alone in Propofol group and in combination with Fentanyl in the Propofol + Fentanyl group.

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Fentanyl
Description: Fentanyl will not be used in isolation but will be used in combination with either Midazolam or Propofol in Midazolam + Fentanyl group and Propofol + Fentanyl group, respectively.

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Fentanyl
Description: Fentanyl will not be used in isolation but will be used in combination with either Midazolam or Propofol in Midazolam + Fentanyl group and Propofol + Fentanyl group, respectively.
Study: NCT06763523

Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: arthroereisis of the subtalar joint
Description: arthroereisis alone versus arthroereisis combined with corrective osteotomies

Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: arthroereisis of the subtalar joint
Description: arthroereisis alone versus arthroereisis combined with corrective osteotomies
Study: NCT06762912

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Passive application of BFR cuff
Description: The first experimental session will start by conducting the one repetition maximum (1-RM) test of unilateral knee extension of the dominant leg, in which the dominant side was identified by asking the participants which side they will use to kick a ball. Before conducting the 1-RM test, 5 minutes warm-up on the cycle ergometer at 75W will be done. Calibration of the dynamometer will be done before operating the machine with each participant, then the participant will be positioned on the dynamometer seat comfortably with ensuring the back is supported and the knee is aligned with the axis of rotation. The participant will be asked to complete one successful repetition of knee extension through full range of motion (ROM), with increasing load until the participant can no longer complete full knee extension ROM, 3 minutes of rest will be allowed between attempts until the 1-RM is identified.

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Resistance exercise with BFR
Description: For both experimental sessions 2 and 3, the order of exercise condition will be randomly selected, either to be (1) the application of BFR cuff with resistance exercise, or (2) resistance exercise without the application of BFR cuff to decrease the incidence of learning effect. Cuff pressure during the application of BFR will be standardized to 50% of AOP.~The resistance exercise for both experimental sessions 2 and 3 will be exactly similar and will involve four sets of isometric knee extensions at an intensity of 20% of 1-RM with repetitions of 30, 15, 15, and 15 by using the isokinetic dynamometer machine, which has a good to excellent test-retest reliability for knee extension movement with ICC value of 0.95-0.99. To minimize cognitive and neuromuscular fatigue, the experimental sessions will be separated by a minimum of three days (72 hours).

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Resistance exercise without BFR
Description: For both experimental sessions 2 and 3, the order of exercise condition will be randomly selected, either to be (1) the application of BFR cuff with resistance exercise, or (2) resistance exercise without the application of BFR cuff to decrease the incidence of learning effect. Cuff pressure during the application of BFR will be standardized to 50% of AOP.~The resistance exercise for both experimental sessions 2 and 3 will be exactly similar and will involve four sets of isometric knee extensions at an intensity of 20% of 1-RM with repetitions of 30, 15, 15, and 15 by using the isokinetic dynamometer machine, which has a good to excellent test-retest reliability for knee extension movement with ICC value of 0.95-0.99. To minimize cognitive and neuromuscular fatigue, the experimental sessions will be separated by a minimum of three days (72 hours).
Study: NCT06763367

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Face mask containing Centella sinensis
Description: A half-face control test was used in this study. One side of the face was treated with a mask containing Asiaticum asiatica and the other side was treated with a mask without Asiaticum asiatica
Study: NCT06764030

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Educational web-based application
Description: BRIDGES is a patient-directed computerized universal education on RC that is delivered within the FP setting, and that does not require the patient to disclose RC experiences to learn about RC.
Study: NCT06764836

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: IMM27M
Description: Intravenous injection

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: IMM2510
Description: Intravenous injection
Study: NCT06763913

Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: taVNS
Description: Set the pulse width to 200 microseconds, frequency to 30 Hz, and start the current at 10 mA. Gradually increase the current until the patient reaches their pain tolerance threshold, and cap it at 50 mA，last for one hour.During the intervention, dynamic ECG monitoring was conducted using an ECG monitor, starting 10 minutes before the stimulation and ending 10 minutes after the stimulation.

Intervention type: DEVICE
Group type: SHAM_COMPARATOR
Intervention: sham taVNS
Description: Set the pulse width to 200 microseconds, frequency to 1 Hz, and start the current at 10 mA. Gradually increase the current until the patient reaches their pain tolerance threshold, and cap it at 50 mA，last for one hour.During the intervention, dynamic ECG monitoring was conducted using an ECG monitor, starting 10 minutes before the stimulation and ending 10 minutes after the stimulation.